Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Jun 09, 2010 12:21am
686 Views
Post# 17171475

RE: RE: RE: Questions

RE: RE: RE: QuestionsI felt they thought they were proving their integrity by doing it as they did. Open the data after close Friday and release the results before the open Tuesday (long weekend) left NO opportunity for anyone to trade on any kind of insider knowledge. They were TRYING to do the right thing IMO.

As you say hindsight being 20-20 and all, time to move forward
TW
Bullboard Posts